FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2907608712> ?p ?o ?g. }

• W2907608712 endingPage "854" @default.
• W2907608712 startingPage "847" @default.
• W2907608712 abstract "•Renal function overestimation occurs frequently in patients with liver cirrhosis when using serum creatinine. •Decreased muscle mass impacts on overestimation of kidney function especially in male patients with cirrhosis. •Compared to creatinine, cystatin C correlated better with mGFR and had a higher predictive ability for clinical outcomes. •Cystatin C might be a promising marker to accurately assess renal function in cirrhotic patients. Background & Aims Accurate evaluation of renal function in patients with liver cirrhosis is critical for clinical management. However, there are still discrepancies between the measured glomerular filtration rate (mGFR) and creatinine-based estimated GFR (eGFR). In this study, we compared the performance of 2 common eGFR measurements with mGFR and evaluated the impact of low muscle mass on overestimation of renal function in patients with cirrhosis. Methods This study included 779 consecutive cirrhotic patients who underwent 51Cr-ethylenediamine tetra acetic acid (EDTA) (as a mGFR) and abdominal computed tomography (CT). The eGFR was calculated using creatinine or cystatin C. Muscle mass was assessed in terms of the total skeletal muscle at L3 level using CT. Results Modification of diet in renal disease (MDRD)-eGFR was overestimated in 47% of patients. A multivariate analysis showed that female sex (adjusted odds ratio [aOR] 4.91), Child B and C vs. A (aOR 1.69 and 1.84) and skeletal muscle mass (aOR 0.89) were independent risk factors associated with overestimation. Interestingly, the effect of skeletal muscle mass on overestimation varied based on sex. Decreased muscle mass significantly enhanced the risk of overestimation of MDRD-eGFR in male patients, but not in female patients. Cystatin C-based eGFR showed a better correlation with mGFR than MDRD-eGFR; it was also better at predicting overall survival and the incidence of acute kidney injury than MDRD-eGFR. Conclusions The risk factors associated with overestimation included female sex, impaired liver function, and decreased muscle mass in males. In particular, eGFR in male patients with sarcopenia should be carefully interpreted. Creatinine-based eGFR was overestimated more often than cystatin C-based eGFR, with overestimation of eGFR closely related to poor prognostic performance. Lay summary Overestimation of renal function frequently occurs in patients with liver cirrhosis when using serum creatinine. Decreased muscle mass has a great impact on overestimation of kidney function especially in male patients with cirrhosis. Compared with creatinine, cystatin C was more closely correlated with measured glomerular filtration rate and had a higher predictive ability for renal complications and survival than creatinine. Accurate evaluation of renal function in patients with liver cirrhosis is critical for clinical management. However, there are still discrepancies between the measured glomerular filtration rate (mGFR) and creatinine-based estimated GFR (eGFR). In this study, we compared the performance of 2 common eGFR measurements with mGFR and evaluated the impact of low muscle mass on overestimation of renal function in patients with cirrhosis. This study included 779 consecutive cirrhotic patients who underwent 51Cr-ethylenediamine tetra acetic acid (EDTA) (as a mGFR) and abdominal computed tomography (CT). The eGFR was calculated using creatinine or cystatin C. Muscle mass was assessed in terms of the total skeletal muscle at L3 level using CT. Modification of diet in renal disease (MDRD)-eGFR was overestimated in 47% of patients. A multivariate analysis showed that female sex (adjusted odds ratio [aOR] 4.91), Child B and C vs. A (aOR 1.69 and 1.84) and skeletal muscle mass (aOR 0.89) were independent risk factors associated with overestimation. Interestingly, the effect of skeletal muscle mass on overestimation varied based on sex. Decreased muscle mass significantly enhanced the risk of overestimation of MDRD-eGFR in male patients, but not in female patients. Cystatin C-based eGFR showed a better correlation with mGFR than MDRD-eGFR; it was also better at predicting overall survival and the incidence of acute kidney injury than MDRD-eGFR. The risk factors associated with overestimation included female sex, impaired liver function, and decreased muscle mass in males. In particular, eGFR in male patients with sarcopenia should be carefully interpreted. Creatinine-based eGFR was overestimated more often than cystatin C-based eGFR, with overestimation of eGFR closely related to poor prognostic performance." @default.
• W2907608712 created "2019-01-11" @default.
• W2907608712 creator A5004006347 @default.
• W2907608712 creator A5008459886 @default.
• W2907608712 creator A5026480334 @default.
• W2907608712 creator A5036816797 @default.
• W2907608712 creator A5051951378 @default.
• W2907608712 creator A5057447649 @default.
• W2907608712 creator A5065876999 @default.
• W2907608712 creator A5068532045 @default.
• W2907608712 creator A5072844970 @default.
• W2907608712 creator A5076451607 @default.
• W2907608712 creator A5083728536 @default.
• W2907608712 date "2019-05-01" @default.
• W2907608712 modified "2023-10-18" @default.
• W2907608712 title "Estimation of renal function in patients with liver cirrhosis: Impact of muscle mass and sex" @default.
• W2907608712 cites W1550111394 @default.
• W2907608712 cites W1567330416 @default.
• W2907608712 cites W1971120042 @default.
• W2907608712 cites W1975587900 @default.
• W2907608712 cites W1997016172 @default.
• W2907608712 cites W1999834979 @default.
• W2907608712 cites W2010903159 @default.
• W2907608712 cites W2011389873 @default.
• W2907608712 cites W2011458442 @default.
• W2907608712 cites W2012357491 @default.
• W2907608712 cites W2027869317 @default.
• W2907608712 cites W2042178933 @default.
• W2907608712 cites W2055864845 @default.
• W2907608712 cites W2061354013 @default.
• W2907608712 cites W2061670714 @default.
• W2907608712 cites W2065305173 @default.
• W2907608712 cites W2068633232 @default.
• W2907608712 cites W2073374685 @default.
• W2907608712 cites W2073742622 @default.
• W2907608712 cites W2078807443 @default.
• W2907608712 cites W2090825088 @default.
• W2907608712 cites W2104593676 @default.
• W2907608712 cites W2116361089 @default.
• W2907608712 cites W2118625269 @default.
• W2907608712 cites W2123664981 @default.
• W2907608712 cites W2139777675 @default.
• W2907608712 cites W2141348928 @default.
• W2907608712 cites W2141366764 @default.
• W2907608712 cites W2280336996 @default.
• W2907608712 cites W2396013415 @default.
• W2907608712 cites W2565339423 @default.
• W2907608712 cites W2578580786 @default.
• W2907608712 cites W2620213515 @default.
• W2907608712 cites W4211008388 @default.
• W2907608712 cites W878138526 @default.
• W2907608712 doi "https://doi.org/10.1016/j.jhep.2018.12.030" @default.
• W2907608712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30630010" @default.
• W2907608712 hasPublicationYear "2019" @default.
• W2907608712 type Work @default.
• W2907608712 sameAs 2907608712 @default.
• W2907608712 citedByCount "58" @default.
• W2907608712 countsByYear W29076087122019 @default.
• W2907608712 countsByYear W29076087122020 @default.
• W2907608712 countsByYear W29076087122021 @default.
• W2907608712 countsByYear W29076087122022 @default.
• W2907608712 countsByYear W29076087122023 @default.
• W2907608712 crossrefType "journal-article" @default.
• W2907608712 hasAuthorship W2907608712A5004006347 @default.
• W2907608712 hasAuthorship W2907608712A5008459886 @default.
• W2907608712 hasAuthorship W2907608712A5026480334 @default.
• W2907608712 hasAuthorship W2907608712A5036816797 @default.
• W2907608712 hasAuthorship W2907608712A5051951378 @default.
• W2907608712 hasAuthorship W2907608712A5057447649 @default.
• W2907608712 hasAuthorship W2907608712A5065876999 @default.
• W2907608712 hasAuthorship W2907608712A5068532045 @default.
• W2907608712 hasAuthorship W2907608712A5072844970 @default.
• W2907608712 hasAuthorship W2907608712A5076451607 @default.
• W2907608712 hasAuthorship W2907608712A5083728536 @default.
• W2907608712 hasConcept C126322002 @default.
• W2907608712 hasConcept C126894567 @default.
• W2907608712 hasConcept C134018914 @default.
• W2907608712 hasConcept C156957248 @default.
• W2907608712 hasConcept C159641895 @default.
• W2907608712 hasConcept C2776214593 @default.
• W2907608712 hasConcept C2777214474 @default.
• W2907608712 hasConcept C2778653478 @default.
• W2907608712 hasConcept C2779548226 @default.
• W2907608712 hasConcept C2780306776 @default.
• W2907608712 hasConcept C2992343062 @default.
• W2907608712 hasConcept C71924100 @default.
• W2907608712 hasConcept C90924648 @default.
• W2907608712 hasConceptScore W2907608712C126322002 @default.
• W2907608712 hasConceptScore W2907608712C126894567 @default.
• W2907608712 hasConceptScore W2907608712C134018914 @default.
• W2907608712 hasConceptScore W2907608712C156957248 @default.
• W2907608712 hasConceptScore W2907608712C159641895 @default.
• W2907608712 hasConceptScore W2907608712C2776214593 @default.
• W2907608712 hasConceptScore W2907608712C2777214474 @default.
• W2907608712 hasConceptScore W2907608712C2778653478 @default.
• W2907608712 hasConceptScore W2907608712C2779548226 @default.
• W2907608712 hasConceptScore W2907608712C2780306776 @default.
• W2907608712 hasConceptScore W2907608712C2992343062 @default.

• next